Observations placeholder
Xolair
Identifier
020387
Type of Spiritual Experience
Background
A description of the experience
Omalizumab, sold under the trade name Xolair, is a humanized antibody originally designed to reduce sensitivity to inhaled or ingested allergens, especially in the control of moderate to severe allergic asthma, which does not respond to high doses of corticosteroids. It has been approved for treating adult and adolescent patients 12 years and older with severe or moderate to severe allergic asthma in more than 90 countries, since its first of such approval in 2002 in Australia. Omalizumab was approved in March 2014 in the European Union and the U.S.A. and in about 10 other countries for treating patients 12 years and above with chronic spontaneous urticaria (CSU) (also referred to as chronic idiopathic urticaria or CIU), which cannot be treated with H1-antihistamines. CSU is not an allergic disease. Presently, the drug is being actively studied in clinical trials for various allergic diseases and some non-allergic diseases, especially skin diseases.
Adverse effects
The main adverse effect is anaphylaxis (a life-threatening systemic allergic reaction). The patients who use omalizumab are generally highly allergic. Thus, even though the drug is administered with the purpose to suppress allergy (including anaphylactic reactions), it does not work immediately after injection [sic].
It also increases the risk of strokes and heart disease.
On Jan, 10, 2017 20,544 people reported to have side effects when taking Xolair.
Among them, 19 people (0.09%) have Hallucination
Time on Xolair when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Xolair :
| Female | Male | |
| Hallucination | 66.67% | 33.33% |
Age of people who have Hallucination when taking Xolair :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 14.29% | 0.00% | 85.71% |
On Feb, 2, 2016: 11,502 people reported to have side effects when taking Xolair. Among them, 347 people (3.02%) have Death.
Time on Xolair when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 41.94% | 6.45% | 0.00% | 22.58% | 19.35% | 9.68% | 0.00% |
Gender of people who have Death when taking Xolair :
| Female | Male | |
| Death | 64.16% | 35.84% |
Age of people who have Death when taking Xolair :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.00% | 3.64% | 0.91% | 5.45% | 19.09% | 27.27% | 43.64% |
Top conditions involved for these people :
- Asthma (186 people, 53.60%)
- Rhinitis allergic (22 people, 6.34%)
- Chronic obstructive pulmonary disease (7 people, 2.02%)
- Allergic bronchitis (4 people, 1.15%)
- Lung infection (4 people, 1.15%)